ConductScience.org, home

Paper14746554

The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.

Merlini G and 1 other. J Intern Med, 2004. Cited by 146 papers, by iCite.

Cite this record

ConductScience Library. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. Papers, record 14746554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14746554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.
PubMed
Journal
J Intern Med
PubMed
Year
2004
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
146
iCite
Relative citation ratio, by iCite
3.65
iCite
Revised in PubMed
2025-05-29
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Merlini GG
2Westermark PP

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmyloidMajor topic
AmyloidosisMajor topic
Humans

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
E.0793TelethonItalyPubMed

Source PubMed

Download CSV of grants

Cited by60

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.

PMIDTitleJournalYearIn PapersSource
42809190Unraveling cardiac amyloidosis in Egypt: diagnostic challenges and disease outcomes.Egypt Heart J2026https://conductscience.org/library/papers/42809190PubMed
41659097Bridging the Gap in AL and ATTR Cardiac Amyloidosis: Integrating Histopathology, Biomarkers, and Multimodal Imaging for Subtype-Specific Diagnosis.Rev Cardiovasc Med2026https://conductscience.org/library/papers/41659097PubMed
41059241Primary Localized Conjunctival Amyloidosis Mimicking Lymphoma.Beyoglu Eye J2025https://conductscience.org/library/papers/41059241PubMed
40985278Central nervous system involvement in cardiac amyloidosis: Redefining the heart-brain axis.Eur J Clin Invest2026https://conductscience.org/library/papers/40985278PubMed
40142821Transthyretin Amyloid Cardiomyopathy: Current Diagnostic Approach and Risk Stratification with Multimodality Imaging.J Clin Med2025https://conductscience.org/library/papers/40142821PubMed
40093801Knowledge Landscape and Hotspots of Research in Transthyretin Amyloid Cardiomyopathy: A Bibliometric Analysis.Int J Med Sci2025https://conductscience.org/library/papers/40093801PubMed
39857067A Narrative Review of Biomarkers and Imaging in the Diagnosis of Acute Aortic Syndrome.Diagnostics (Basel)2025https://conductscience.org/library/papers/39857067PubMed
37381778Amyloidogenic light chains impair plasma cell survival.Haematologica2023https://conductscience.org/library/papers/37381778PubMed
36341129Multidisciplinary amyloidosis care in the era of personalized medicine.Front Neurol2022https://conductscience.org/library/papers/36341129PubMed
36217437Contrasting presentations of the same disease: A comparison of two cases of amyloidosis presenting with eyelid involvement.Am J Ophthalmol Case Rep2022https://conductscience.org/library/papers/36217437PubMed
35524881Imaging-Guided Treatment for Cardiac Amyloidosis.Curr Cardiol Rep2022https://conductscience.org/library/papers/35524881PubMed
34641582Common Factors of Alzheimer's Disease and Rheumatoid Arthritis-Pathomechanism and Treatment.Molecules2021https://conductscience.org/library/papers/34641582PubMed
34129344Cardiac Amyloidosis: Multimodal Imaging of Disease Activity and Response to Treatment.Circ Cardiovasc Imaging2021https://conductscience.org/library/papers/34129344PubMed
33693246Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis.Circ Rep2020https://conductscience.org/library/papers/33693246PubMed
32735824Expression of Amyloidogenic Transthyretin Drives Hepatic Proteostasis Remodeling in an Induced Pluripotent Stem Cell Model of Systemic Amyloid Disease.Stem Cell Reports2020https://conductscience.org/library/papers/32735824PubMed
32042139Diagnostic imaging of cardiac amyloidosis.Nat Rev Cardiol2020https://conductscience.org/library/papers/32042139PubMed
31993048Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses.Front Immunol2019https://conductscience.org/library/papers/31993048PubMed
31452023Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis.Clin Auton Res2019https://conductscience.org/library/papers/31452023PubMed
29700090Cardiac amyloidosis.Clin Med (Lond)2018https://conductscience.org/library/papers/29700090PubMed
29449366Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin.Circ Heart Fail2018https://conductscience.org/library/papers/29449366PubMed

See all 60 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14746554

GET https://conductscience.org/api/papers/v1/14746554/cited_by?page=2